We are live on
!
Find out more
CAI
Caris Life Sciences
186 hedge funds and large institutions have $3.92B invested in Caris Life Sciences in 2025 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 63 increasing their positions, 30 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
185% more first-time investments, than exits
New positions opened: 77 | Existing positions closed: 27
184% more call options, than puts
Call options by funds: $14.4M | Put options by funds: $5.09M
110% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 30
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
35% more funds holding
Funds holding: 138 → 186 (+48)
15% more capital invested
Capital invested by funds: $3.41B → $3.92B (+$507M)
11.18% more ownership
Funds ownership: 40.33% → 51.5% (+11%)
Holders
186
Holders Change
+48
Holders Change %
+34.78%
% of All Funds
2.26%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.09%
New
77
Increased
63
Reduced
30
Closed
27
Calls
$14.4M
Puts
$5.09M
Net Calls
+$9.35M
Net Calls Change
-$1.32M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$129M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$87.7M |
| 3 |
PC
PointState Capital
New York
|
+$79.8M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$54.9M |
| 5 |
BlackRock
New York
|
+$48.6M |
Top Sellers
| 1 |
SLG
Silver Lake Group
Menlo Park,
California
|
-$160M |
| 2 |
SSP
Sixth Street Partners
Dallas,
Texas
|
-$141M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$59.1M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$33.3M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$33.3M |
